Whether driving immune evasion in pancreatic and gastric cancers or mediating cross-talk between epithelial self-defense and microenvironmental signals in colorectal cancer, ZC3H12A inactivation consistently propels more malignant tumor phenotypes. The gene discussed is ZC3H12A; the disease is gastric cancer.